These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
390 related items for PubMed ID: 20373036
1. Health-related quality of life and disability in patients with rheumatoid, early rheumatoid and early psoriatic arthritis treated with etanercept. Picchianti-Diamanti A, Germano V, Ferlito C, Migliore A, D'Amelio R, Laganà B. Qual Life Res; 2010 Aug; 19(6):821-6. PubMed ID: 20373036 [Abstract] [Full Text] [Related]
2. Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment. Strand V, Sharp V, Koenig AS, Park G, Shi Y, Wang B, Zack DJ, Fiorentino D. Ann Rheum Dis; 2012 Jul; 71(7):1143-50. PubMed ID: 22258482 [Abstract] [Full Text] [Related]
5. Improved health outcomes with etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis. Bae SC, Gun SC, Mok CC, Khandker R, Nab HW, Koenig AS, Vlahos B, Pedersen R, Singh A. BMC Musculoskelet Disord; 2013 Jan 08; 14():13. PubMed ID: 23294908 [Abstract] [Full Text] [Related]
6. Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability. Baumgartner SW, Fleischmann RM, Moreland LW, Schiff MH, Markenson J, Whitmore JB. J Rheumatol; 2004 Aug 08; 31(8):1532-7. PubMed ID: 15290731 [Abstract] [Full Text] [Related]
7. Real-world anti-tumor necrosis factor treatment in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: cost-effectiveness based on number needed to treat to improve health assessment questionnaire. Barra L, Pope JE, Payne M. J Rheumatol; 2009 Jul 08; 36(7):1421-8. PubMed ID: 19487267 [Abstract] [Full Text] [Related]
8. Patient-reported outcomes in a randomized trial of etanercept in psoriatic arthritis. Mease PJ, Woolley JM, Singh A, Tsuji W, Dunn M, Chiou CF. J Rheumatol; 2010 Jun 08; 37(6):1221-7. PubMed ID: 20395648 [Abstract] [Full Text] [Related]
9. Older age at rheumatoid arthritis onset and comorbidities correlate with less Health Assessment Questionnaire-Disability Index and Clinical Disease Activity Index response to etanercept in the RADIUS 2 registry. Martin WJ, Shim M, Paulus HE, Chaudhari S, Feng J, Elashoff D, Hahn TJ, Ranganath VK, RADIUS Investigators. J Clin Rheumatol; 2014 Sep 08; 20(6):301-5. PubMed ID: 25160011 [Abstract] [Full Text] [Related]
10. Health-related quality of life and functional status of patients with rheumatoid arthritis randomly assigned to receive etanercept or placebo. Mathias SD, Colwell HH, Miller DP, Moreland LW, Buatti M, Wanke L. Clin Ther; 2000 Jan 08; 22(1):128-39. PubMed ID: 10688396 [Abstract] [Full Text] [Related]
13. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A. Health Technol Assess; 2006 Nov 08; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139 [Abstract] [Full Text] [Related]